Patents by Inventor Odelya E. Pagovich

Odelya E. Pagovich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190160187
    Abstract: A vector comprising a promoter operably linked to a nucleic acid sequence encoding human aldehyde dehydrogenase, as well as a composition comprising the vector and method of using the vector to treat aldehyde dehydrogenase deficiency, or to prevent or treat a disease characterized by aldehyde dehydrogenase deficiency.
    Type: Application
    Filed: July 26, 2017
    Publication date: May 30, 2019
    Applicants: Cornell University, Adverum Biotechnologies, Inc.
    Inventors: Mehdi Gasmi, Ronald G. Crystal, Odelya E. Pagovich
  • Patent number: 10293059
    Abstract: This invention is directed to a vector which comprises a promoter operably linked to a nucleic acid sequence encoding a therapeutic gene that blocks allergic reactions. The invention is also directed to a composition comprising the vector and method of using the vector to reduce or inhibit an immune response or allergic reaction to an allergen in a mammal.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: May 21, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Ronald G. Crystal, Odelya E. Pagovich, Maria J. Chiuchiolo
  • Publication number: 20190119653
    Abstract: This invention is directed to a vector which comprises a promoter operably linked to a nucleic acid sequence encoding the human C1 esterase inhibitor or Factor XII. The invention is also directed to a composition comprising the vector and a method of using the vector to treat or prevent hereditary angioedema.
    Type: Application
    Filed: January 4, 2019
    Publication date: April 25, 2019
    Inventors: Ronald G. Crystal, Odelya E. Pagovich, Maria J. Chiuchiolo
  • Patent number: 10214731
    Abstract: This invention is directed to a vector which comprises a promoter operably linked to a nucleic acid sequence encoding the human C1 esterase inhibitor or Factor XII. The invention is also directed to a composition comprising the vector and a method of using the vector to treat or prevent hereditary angioedema.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: February 26, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Ronald G. Crystal, Odelya E. Pagovich, Maria J. Chiuchiolo
  • Publication number: 20160347822
    Abstract: This invention is directed to a vector which comprises a promoter operably linked to a nucleic acid sequence encoding the human C1 esterase inhibitor or Factor XII. The invention is also directed to a composition comprising the vector and a method of using the vector to treat or prevent hereditary angioedema.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Inventors: Ronald G. Crystal, Odelya E. Pagovich, Maria J. Chiuchiolo
  • Publication number: 20160296638
    Abstract: This invention is directed to a vector which comprises a promoter operably linked to a nucleic acid sequence encoding a therapeutic gene that blocks allergic reactions. The invention is also directed to a composition comprising the vector and method of using the vector to reduce or inhibit an immune response or allergic reaction to an allergen in a mammal.
    Type: Application
    Filed: April 11, 2016
    Publication date: October 13, 2016
    Inventors: Ronald G. Crystal, Odelya E. Pagovich, Maria J. Chiuchiolo